论文信息 - Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors. - 字舞流文

Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors.

L. Rimsza | Y. Lussier | W. Liang | J. Schatz | J. Adkins | L. Cuyugan | S. Puvvada | S. Rajan | A. Amin | M. Groysman | Praechompoo Pongtornpipat | T. Peters | Edgar O. Tapia